Skip to main content
. 2021 Feb 4;12:632535. doi: 10.3389/fneur.2021.632535
Immunosuppressive and immunomodulatory agents Total number of patients n (%) Autoimmune diseases with chronic immunomodulatory therapy n (%) Hematological malignancies n (%) Solid tumors, Organ transplants n (%) Sarcoidosis n (%) Mixed connective tissue disease n (%)
Natalizumab 5/37 (13,5) 5/6 (83) 0 (0) 0 (0) 0 (0) 0 (0)
Allogenic stem cell transplantation 2/37 (5) 0 (0) 2/6 (33) 0 (0) 0 (0) 0 (0)
Other immunosuppressive agents
   Combination chemotherapy* 5/37 (13,5) 0 (0) 5/6 (83) 1/2 (50) 0 (0) 0 (0)
   Prednisolon only 1/37 (3) 0 (0) 0 (0) 0 (0) 1/5 (3) 0 (0)
   Tacrolimus 1/37 (3) 0 (0) 0 (0) 1/2 (50) 0 (0) 0 (0)
   Azathioprine 3/37 (8) 1/6 (17) 0 (0) 0 (0) 1/5 (3) 1/1 (100)
   Methotrexate 1/37 (3) 0 (0) 0 (0) 0 (0) 1/5 (3) 0 (0)
a

HIV/ AIDS, Human immunodeficiency virus/ Acquired Immune Deficiency Syndrome.

b

PSC, primary sclerosing cholangitis; AIH, autoimmune Hepatitis.

*

One patient was diagnosed with both, a solid tumor and a hematological malignancy.